Mouthpiece for Chemotherapy Induced Oral Mucositis in Cancer Patients
Protocol: STUDY00004783
Full Title
A Randomized, Prospective, Multi-center Trial to Assess the Efficacy of a Cryotherapy Device Versus est Supportive Oral Care in Mitigating Symptoms of Oral Mucositis in Patients Receiving Chemotherapy for the Treatment of Cancer
Description
This is a study to evaluate the efficacy of Chemo Mouthpiece® in minimizing patient-reported symptoms associated with oral mucositis in cancer patients receiving chemotherapy. The Chemo Mouthpiece(R) is a novel device to make it easier to deliver cryotherapy (ice chips).

Technical Description

(CSR 200729353160) This is a post-market, randomized, prospective, multi-center study conducted to assess theefficacy and utility of a novel oral cryotherapy delivery device in mitigating symptomsassociated with chemotherapy-induced oral mucositis in patients being treated with standardstomatotoic chemotherapy regimens.Cryotherapy delivered by ice chips has been advocated for patients at risk for
Compensation: No
Eligibility
Aged 18-80 years
Planned to receive at least 2 cycles of infused stomatotoxic chemotherapy regimens
Be willing and able to complete all study-related activities
Age Group: Adults
Principal Investigator: Carly Gerretsen
Contact(s)
JAMES ZEMER
jameszem@buffalo.edu
+1 716-645-2521
Want to Learn More?
Let us know how the study team can reach you. If you do not hear back within 2 business days, reach out to the study team directly at the contact information above or email ctsiresearch@buffalo.edu and someone will assist you.